13F filer · CIK 1594954
FT Options LLC
CHICAGO, IL · filing since Q4 2015 · last filing Nov 13, 2017
Reported value
$116.4M
+$21.0M vs prior
Positions
345
New / sold out
178 / 125
Added / reduced
79 / 68
Turnover
34.5%
buys $52.0M · sells $36.5M
Top-10 weight
42.1%
Biggest buys vs Q1 2016
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | MEDIVATION INC | +80,980 | +212.2% | +$4.9M |
| Added | BIOGEN INC | +13,516 | +1211.1% | +$3.3M |
| Added | CAL MAINE FOODS INC | +59,189 | +258.6% | +$2.6M |
| New | BRISTOL MYERS SQUIBB CO | +35,075 | – | +$2.6M |
| Added | APPLE INC | +23,487 | +438.4% | +$2.2M |
| New | BIOMARIN PHARMACEUTICAL INC | +21,373 | – | +$1.7M |
| New | SAREPTA THERAPEUTICS INC | +60,908 | – | +$1.2M |
| New | CASCADIAN THERAPEUTICS INC | +1,117,661 | – | +$1.1M |
| New | JNJJOHNSON & JOHNSON | +8,606 | – | +$1.0M |
| Added | YAHOO INC | +25,100 | +478.9% | +$943.1K |
247 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2016
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | BAXTER INTL INC | -100,000 | -100.0% | $-4.1M |
| Reduced | VALEANT PHARMACEUTICALS INTLPUT | -84,400 | -62.5% | $-2.6M |
| Reduced | GILEAD SCIENCES INC | -22,500 | -82.1% | $-1.9M |
| Reduced | INTERNATIONAL BUSINESS MACHS | -9,912 | -99.0% | $-1.5M |
| Sold out | BAXTER INTL INCPUT | -100,000 | -100.0% | $-1.4M |
| Sold out | ONCOTHYREON INC | -1,015,607 | -100.0% | $-1.3M |
| Reduced | ACADIA PHARMACEUTICALS INCCALL | -103,800 | -90.5% | $-1.1M |
| Sold out | CHIPOTLE MEXICAN GRILL INC | -1,974 | -100.0% | $-930.0K |
| Sold out | EXPEDIA INC DEL | -8,481 | -100.0% | $-914.0K |
| Sold out | TIME WARNER CABLE INC | -4,151 | -100.0% | $-849.0K |
183 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2016
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | REGENERON PHARMACEUTICALSCOM | 31,354 | $10.9M | 9.40% |
| 2 | REGENERON PHARMACEUTICALSPUTCOM | 47,000 | $7.6M | 6.51% |
| 3 | MEDIVATION INCCOM | 119,135 | $7.2M | 6.17% |
| 4 | ABBOTT LABSCOM | 127,252 | $5.0M | 4.30% |
| 5 | CAL MAINE FOODS INCCOM NEW | 82,081 | $3.6M | 3.12% |
| 6 | BIOGEN INCCOM | 14,632 | $3.5M | 3.04% |
| 7 | OTONOMY INCCOM | 192,785 | $3.1M | 2.63% |
| 8 | APPLE INCCOM | 28,844 | $2.8M | 2.37% |
| 9 | AKEBIA THERAPEUTICS INCCOM | 367,276 | $2.7M | 2.36% |
| 10 | BRISTOL MYERS SQUIBB COCOM | 35,075 | $2.6M | 2.22% |
335 more rows. Subscribe for $29/month to see every row, download the data and use the API.